Delivery Order SPE2DB20D3303-SPE2DB25FA0WP
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical supply item, with a completion date of July 3, 2025 and a ceiling value of $1,028.39. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp is the prime contractor, and this award is part of the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a medical inhaler product, BREYNA 160-4.5 MCG INHALER 10.3GM, with a ceiling value of $5,740.40 and a period of performance through April 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,280.97, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. It is a Firm Fixed Price contract with a period of performance through March 26, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,376.54 and an ultimate completion date of June 24, 2025. The contract is for the delivery of the pharmaceutical product BREYNA 160-4.5 MCG INHALER 10.3GM. It is not designated as a set-aside contract, indicating open competition....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 80-4.5 MCG INHALER 10.3GM, a medical product, with a ceiling value of $1,151.55 and a period of performance through April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. The award is part of Amerisourcebergen's larger...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the pharmaceutical product BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a ceiling value of $4,359.04 and a performance period through July 2, 2025. The contract is not set aside and allows for the delivery of brand-name and generic pharmaceutical products to support various federal medical programs,...
- This is a $2,353.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product, to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the BREYNA 160-4.5 MCG INHALER 10.3GM medication. The contract has a firm fixed price of $2,428.87 and an ultimate completion date of September 20, 2024. Amerisourcebergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary...
- This is a $1,113.36 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of a specific medical inhaler product, BREYNA 160-4.5 MCG INHALER 10.3GM, with a period of performance running through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,991.16 order is for the supply of 4,564,257,958 units of the BREYNA 160-4.5 MCG INHALER 10.3GM pharmaceutical product. The contract has an ultimate completion date of April 15, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA0WPDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the drug product BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a ceiling value of $1,203.46 and a completion date of July 1, 2025. The award is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is issued under that larger IDC contract, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/30/25 |